1369377-26-3

Basic information

• Product Name: (4-chlorophenyl)(4-hydroxy-1,1-dioxido-2H-1,2-benzothiazin-3-yl)methanone
• Synonyms: (4-chlorophenyl)(4-hydroxy-1,1-dioxido-2H-1,2-benzothiazin-3-yl)methanone
• CAS NO: 1369377-26-3
• Molecular Weight: 335.768
• Mol File: 1369377-26-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (4-chlorophenyl)(4-hydroxy-1,1-dioxido-2H-1,2-benzothiazin-3-yl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chlorophenyl)(4-hydroxy-1,1-dioxido-2H-1,2-benzothiazin-3-yl)methanone(1369377-26-3)
• EPA Substance Registry System: (4-chlorophenyl)(4-hydroxy-1,1-dioxido-2H-1,2-benzothiazin-3-yl)methanone(1369377-26-3)

Safety Data

• Hazardous Substances Data: 1369377-26-3(Hazardous Substances Data)

Upstream product

• 536-38-9 4-chlorobenzoylmethyl bromide 
• 128-44-9 saccharin sodium salt 
• 41335-62-0 2-[2-(4-chlorophenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide 

Downstream Products

• 1369377-34-3 {4-[3-(4-chlorophenyl)-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl]phenyl}amine 
• 1369377-35-4 N-{4-[3-(4-chlorophenyl)-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl]phenyl}methanesulfonamide 
• 1369377-36-5 3-(4-chlorophenyl)-4-methyl-1-phenyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-37-6 3-(4-chlorophenyl)-1-(3-fluorophenyl)-4-methyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-38-7 3-(4-chlorophenyl)-1-(4-fluorophenyl)-4-methyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-39-8 3-(4-chlorophenyl)-4-methyl-1-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-40-1 3-(4-chlorophenyl)-4-methyl-1-[4-(trifluoromethyl)phenyl]-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-41-2 4-[3-(4-chlorophenyl)-4-methyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl]benzenesulfonamide 
• 1369377-42-3 3-(4-chlorophenyl)-4-methyl-1-(4-nitrophenyl)-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-33-2 3-(4-chlorophenyl)-1-(4-nitrophenyl)-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-27-4 3-(4-chlorophenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-29-6 3-(4-chlorophenyl)-1-(4-fluorophenyl)-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-28-5 3-(4-chlorophenyl)-1-(3-fluorophenyl)-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 
• 1369377-31-0 3-(4-chlorophenyl)-1-[4-(trifluoromethyl)phenyl]-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 

Relevant articles and documents

Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents

Novel arylpiperazine-1,2-benzothiazine derivatives have been designed and synthesized as potential anti-inflammatory agents. Their structure and properties have been studied using spectroscopic techniques (1H NMR, 13C NMR, FT-IR), MS

Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) continues to spread worldwide, with 25 million confirmed cases and 800 thousand deaths. Effective treatments to target SARS-CoV-2 are urgently needed. In the present study, we have identified a

The interaction of new piroxicam analogues with lipid bilayers - A calorimetric and fluorescence spectroscopic study

The purpose of the present paper was to assess the ability of new piroxicam analogues to interact with the lipid bilayers. The results of calorimetric and fluorescence spectroscopic experiments of two new synthesized analogues of piroxicam, named PR17 and